Cognitive functions over the course of 1 year in multiple sclerosis patients treated with disease modifying therapies

Conclusions: Cognitive functions remain relatively stable under DMT treatment over 1 year, irrespective of the type of medication. Furthermore, the tests PASAT and SPART should be interpreted cautiously in studies examining performance changes over time. The provided RCI norms may help clinicians to determine whether a difference in two measurements observed in a RRMS patient is reliable.

http://tan.sagepub.com/cgi/content/abstract/9/4/269?rss=1

Source: Therapeutic Advances in Neurological Disorders - June 20, 2016 Category: Neurology Authors: Utz, K. S., Lee, D.-H., Lämmer, A., Waschbisch, A., Linker, R. A., Schenk, T. Tags: Original Research Source Type: research

More News: Gilenya | Multiple Sclerosis | Neurology | Study | Tysabri